E-DUCASS: Educational Strategy on a Vulnerable Population to Improve Cardiovascular Health and Food Insecurity

Sponsor
Maimónides Biomedical Research Institute of Córdoba (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05379842
Collaborator
Carlos III Health Institute (Other)
460
1
3
30.5
15.1

Study Details

Study Description

Brief Summary

The purpose of this study is to demonstrate that an educational program on a healthy lifestyle which increases health literacy could improve long-term health and mitigate food insecurity.

Condition or Disease Intervention/Treatment Phase
  • Other: Education on a healthy lifestyle and health literacy
  • Other: Education on a healthy lifestyle and health literacy
N/A

Detailed Description

A 24-month randomized clinical trial involving vulnerable families (460 participants) at risk of food insecurity to improve cardiovascular health, with an initial basic training workshop followed by randomization into three groups: 1. No further intervention; 2. A traditional advanced intervention model every three months; and 3. E-learning advanced intervention model every 15 days with YouTube videos and WhatsApp messages.

Primary objective:
  • Improve cardiovascular health measured by Life's Simple 7, American Heart Association

Secondary objective

  • Demonstrate whether the intervention improves the food safety score measured according to FAO

  • Study which of the two models of advanced intervention, face-to-face or virtual, improves cardiovascular and food health literacy in the study population.

This project aims to transfer and offer to society this virtual educational strategy as a tool to improve cardiovascular health in other vulnerable populations, in a scientific, efficient, safe, and sustainable way.

Study Design

Study Type:
Interventional
Actual Enrollment :
460 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Prevention
Official Title:
Educational Strategy on a Vulnerable Population to Improve Cardiovascular Health and Mitigate Food Insecurity Through a Sustainable Health Literacy Program
Actual Study Start Date :
Dec 1, 2021
Anticipated Primary Completion Date :
Jun 15, 2024
Anticipated Study Completion Date :
Jun 15, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: 1- Non-intervention

Non-posterior intervention after randomization

Active Comparator: 2- Traditional advanced intervention model

Motivational workshops, every 3 months and with limited cost

Other: Education on a healthy lifestyle and health literacy
Traditional motivational face-to-face workshops with lifestyle (nutritional, physical activity, sleep) advice every 3 months

Active Comparator: 3- E-learning advanced intervention model

Educational workshops, every 15 days, with videos -YouTube channel or WhatsApp/text message

Other: Education on a healthy lifestyle and health literacy
E-learning and digital (with videos -YouTube channel or WhatsApp/text message) educational workshops with lifestyle (nutritional, physical activity, sleep) advice every 15 days

Outcome Measures

Primary Outcome Measures

  1. Cardiovascular Health [24 months]

    Improve cardiovascular health measured by Life's Simple 7 (LS7) score. LS7 score is composed of seven domains (diet, physical activity, body mass index, smoking, blood pressure, total cholesterol and fasting blood glucose). Each of seven domains were ranged from 0 poor to 2 ideal. The total score of LS7 ranged from 0-14 with higher scores indicating better cardiovascular health.

  2. Food insecurity [24 months]

    Improve food insecurity measured by The Food Insecurity Experience Scale Survey Module (FIES-SM) from Food and Agriculture Organization of the United Nations. FIES-SM is composed of eight questions with dichotomous no (0 points)/ yes (1 point) responses. The final score ranged from 0 (no insecurity food) to 8 (worst insecurity food).

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participants from the general population without disabling diseases or whose severity implies a life expectancy of less than five years

  • Informed Consent

Exclusion Criteria:
  • Age less than 12 years or equal to or greater than 80 years, with a life expectancy, not less than 5 years.

  • Patients with established cardiovascular disease

  • Patients with limitations to follow the protocol

  • Serious or difficult-to-control risk factors: Patients with hypertension and diabetes with organic involvement that limits their survival and disabling clinical manifestations of cerebral arteriosclerosis will be excluded.

  • Chronic diseases not related to coronary risk: severe psychiatric diseases, chronic processes requiring treatment such as chronic renal failure, chronic liver disease, neoplasms undergoing treatment, severe and very severe chronic obstructive pulmonary disease, endocrinopathies susceptible to decompensation, and digestive tract diseases.

  • Participants in other clinical trials at screening or within 30 days prior to start.

  • Excessive alcohol and drug abuse

  • Pregnant or lactating women.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Reina Sofia University Hospital Cordoba Spain

Sponsors and Collaborators

  • Maimónides Biomedical Research Institute of Córdoba
  • Carlos III Health Institute

Investigators

  • Principal Investigator: Pablo Pérez Martínez, PhD MD, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Maimónides Biomedical Research Institute of Córdoba
ClinicalTrials.gov Identifier:
NCT05379842
Other Study ID Numbers:
  • PI20/01413
First Posted:
May 18, 2022
Last Update Posted:
Jun 30, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Maimónides Biomedical Research Institute of Córdoba

Study Results

No Results Posted as of Jun 30, 2022